Video yükleniyor...

Video Yüklenemedi

Ana Sayfaya Dön

Dr. Patrick Soon-Shiong just showed Chris Cuomo dramatic before-and-after brain scans of late-stage tumor patients who failed chemo, radiation, and surgery — achieving complete remission with ANKTIVA. No chemo. No radiation. Tumors shrinking dramatically in months. He says: “We got FDA approval to treat patients who failed everything… and...

newstart_2024's profile picture

Camus

462,927 subscribers

282,229 görüntüleme • 6 ay önce •via X (Twitter)

Sağlık & İyilikHaberler & PolitikaBilim & Teknoloji
LIVE

Anya Rossi• Live Now

Private livecam show

35 Yorum

Camus profil fotoğrafı
Camus6 ay önce

Credit: @DrPatrick; @NewsNation;

Holistic Health profil fotoğrafı
Holistic Health6 ay önce

Very promising. I recommend watching his long form interview with Tucker.

Jeff Boone profil fotoğrafı
Jeff Boone6 ay önce

Keep this man safe. The drug companies don't like cures, just endless treatments.

freedom🇨🇦 profil fotoğrafı
freedom🇨🇦6 ay önce

I used to follow Patrick until I noticed he never mentions cheap, repurposed drugs like ivermectin, mebendazole, or fenbendazole. This is a red flag for me, but I hope he succeeds and can make Anktiva affordable. Unfortunately, Anktiva is what Scott Adams took shortly before he rapidly deteriorated and died. @MakisMedicine

Berlinergy profil fotoğrafı
Berlinergy6 ay önce

Yes +check the latest presentation of patient results (before after )here :

Sandy Glass profil fotoğrafı
Sandy Glass6 ay önce

My daughter needs to have ANKTIVA to help replenish her leukocyte count destroyed by chemo. ANKTIVA non-toxic, studied for over 10 years but FDA slow walking approval. Why?

thedude profil fotoğrafı
thedude6 ay önce

are you folks insane, lol,, this guy is classic big pharma: Soon-Shiong is the chairman of Chan Soon-Shiong Family Foundation, a non-profit foundation. He has been a minority owner of the Los Angeles Lakers since 2010, and since June 2018, he has been the owner and executive chairman of the Los Angeles Times.[6] Soon-Shiong's net worth is estimated at US$16.6 billion as of 2026 according to the Bloomberg Billionaires Index and Forbes.[7] He has been called the richest man in Los Angeles and one of the wealthiest doctors in the world.[8]

Carlos_Danger profil fotoğrafı
Carlos_Danger6 ay önce

Why not give this to anyone that's terminal who wants it and use that as trials? My father died from gallbladder cancer. He was late stage 4 when diagnosed. They pumped every poison in his body for six months trying to slow the inevitable. I think it actually sped it up, but we would have gladly taken this if offered.

Chalala🐾🇺🇸 profil fotoğrafı
Chalala🐾🇺🇸6 ay önce

My daughter has brain cancer and has completed radiation and chemo. The chemo has caused her to need three blood transfusions. She should have access to Anktiva. @RobertKennedyJr @US_FDA

Gary profil fotoğrafı
Gary6 ay önce

@XrpHomie $IBRX If anyone hasn’t seen the @NewsNation @ChrisCuomo interview with @DrPatrick, it’s a must watch. Dr. Patrick has shown amazing results on many cancers-patient testimonies at 40 min mark-Aline and Jim- all current had failed until Anktiva-Miracle🙏

BrianSays profil fotoğrafı
BrianSays6 ay önce

Lost my mom to brain cancer is 2019. I hope this proves helpful to those suffering from this horrendous disease

Janet Neustedter profil fotoğrafı
Janet Neustedter6 ay önce

Good information but anything with @ChrisCuomo in it is automatic cringe. He is a tool now and then and has zero credibility

MysteryMavX profil fotoğrafı
MysteryMavX6 ay önce

Fabulous! It should be available immediately, not just late-stage, nothing else works. Why go through all those horrific treatments if this is better?

Brad C profil fotoğrafı
Brad C6 ay önce

The @US_FDA needs to allow this in the US. The fact Saudi Arabia is allowing this but we can’t have this treatment in the US. Because big pharma takes priority is ridiculous.

Gary Gerden profil fotoğrafı
Gary Gerden6 ay önce

@bullishbruk If the medical establishment wasn’t already making billions of the chemotherapy, this treatment would be fast tracked for FDA approval.

Marsha Flewelling profil fotoğrafı
Marsha Flewelling6 ay önce

Right to Try

DougW profil fotoğrafı
DougW6 ay önce

Chris Cuomo can kiss my ass! I have detested him since he and his lowlife brother were the biggest supporters of Herr Fauci and the illegal Bribum mandates! I am familiar with the great doctor Dr. Patrick Soon-Shiong but just wish he wouldn't give that bum a second of his time.

Dr. Tamale Henry Duke profil fotoğrafı
Dr. Tamale Henry Duke6 ay önce

This is groundbreaking! The potential of ANKTIVA could change cancer treatment entirely. Looking forward to more updates on this progress.

Macaroniste profil fotoğrafı
Macaroniste6 ay önce

Didn't work for Scott Adams, though.

TruthS33ker🐭 profil fotoğrafı
TruthS33ker🐭6 ay önce

Oh my … so much to learn …. Soon-Shiong is so much more than most realize 💥💥🧵👇👇

MP profil fotoğrafı
MP6 ay önce

A family member received the Anktiva shot. Shortly after, blood test numbers went out of normal range. When they didn't return to normal by the time he was supposed to receive the second shot, they kicked him out of the trial. Surely your success members look good when you immediately remove people who aren't doing well from the program. This family member was currently doing another standard treatment for his cancer and his continues to do well on that without the Anktiva. Hard to believe this is much more than snake oil.

UnitedWeStand-DividedWeFall profil fotoğrafı
UnitedWeStand-DividedWeFall6 ay önce

Now look into the cost of treatment. Is Not of the cost covered? Millionaires congrats. You found a cure.

SpilDaBeans profil fotoğrafı
SpilDaBeans6 ay önce

Please explain why people have to go through hell before they can receive Anktiva. Why do patients have to be in late stage?

klemens d profil fotoğrafı
klemens d6 ay önce

I don't trust the guy as far as I can throw him. I wouldn't be suprised if his super expensive biologicals contained a healthy dose of fenbendazole and ivermectin on the side.

kelly profil fotoğrafı
kelly6 ay önce

This should be for all stage- Not just late stage!

Jackie Beal profil fotoğrafı
Jackie Beal6 ay önce

I’m hoping it is a cure but it must not always be as Scott Adams used it and still died

Wendi Strauch Mahoney🇺🇸Persevere. profil fotoğrafı
Wendi Strauch Mahoney🇺🇸Persevere.6 ay önce

@WorkAuthority I wonder if it works on multiple myeloma

Bryn Stables 🇳🇿 颜领惠 profil fotoğrafı
Bryn Stables 🇳🇿 颜领惠6 ay önce

Absolutely need larger and longer term trials! Otherwise same issue as Covid vaccine. There is no replacement for time to show harms.

Asbury4040 profil fotoğrafı
Asbury40406 ay önce

Look into the @FLsharkman protocols. It’s the only thing I currently trust.

Cj Stites profil fotoğrafı
Cj Stites6 ay önce

@megbasham please help her

Sera Aurelia X profil fotoğrafı
Sera Aurelia X6 ay önce

This guy is a grifter. Many previous similar projects. Caution.

kerrie Tu profil fotoğrafı
kerrie Tu6 ay önce

How long before this outspken person os gone

Waltz King profil fotoğrafı
Waltz King6 ay önce

@JRPLawyeress Big Pharma will kill it!

Kathy profil fotoğrafı
Kathy6 ay önce

I’m stage 4 stomach cancer and I want it now!

Rachel Buckley profil fotoğrafı
Rachel Buckley6 ay önce

Saudi Arabia allows this treatment so why can't we in the US?

Benzer Videolar

This 70-second clip is spreading like wildfire for a reason. Chris Cuomo asks the question every cancer patient fears: “Are you just giving people false hope?” Dr. Patrick Soon-Shiong doesn’t answer with words. He pulls up actual brain scans. Patient: failed surgery, failed radiation, failed chemo. Result after Anktiva + BioShield protocol: tumor visibly shrinking in months — with NO chemo and NO radiation.“ These aren’t anecdotes. These are scans.” The moment at 0:52-1:00 will stop you in your tracks. This is the same treatment that started saving “no-hope” patients back in 2015-2017 and just keeps delivering complete remissions years later. Watch the full 1:11 clip, see the proof with your own eyes, then tell me: Is this the turning point we’ve all been waiting for? Patients, doctors, caregivers — your voice matters. Drop your reaction below. This deserves to be seen by millions. (Always consult your physician — not medical advice)
1:11

This 70-second clip is spreading like wildfire for a reason. Chris Cuomo asks the question every cancer patient fears: “Are you just giving people false hope?” Dr. Patrick Soon-Shiong doesn’t answer with words. He pulls up actual brain scans. Patient: failed surgery, failed radiation, failed chemo. Result after Anktiva + BioShield protocol: tumor visibly shrinking in months — with NO chemo and NO radiation.“ These aren’t anecdotes. These are scans.” The moment at 0:52-1:00 will stop you in your tracks. This is the same treatment that started saving “no-hope” patients back in 2015-2017 and just keeps delivering complete remissions years later. Watch the full 1:11 clip, see the proof with your own eyes, then tell me: Is this the turning point we’ve all been waiting for? Patients, doctors, caregivers — your voice matters. Drop your reaction below. This deserves to be seen by millions. (Always consult your physician — not medical advice)

Camus

237,819 görüntüleme • 10 ay önce

Of all the casualties in the war on cancer, the most critical have been the most ignored: your NK and T cells. As Dr. Patrick Soon-Shiong explains, while oncology has long treated the anemia and neutropenia caused by chemotherapy, it has overlooked the destruction of the very immune cells that fight cancer. For 35 years, there was no treatment for this catastrophic side effect. That era is over. Dr. Soon-Shiong announces ANKTIVA, the first FDA-approved therapy proven to activate NK cells, T cells, and memory T cells. The result? Documented complete responses in bladder cancer patients, free of disease for over nine years. This breakthrough shatters a long-standing medical blind spot. Whether from chemo, radiation, or a severe viral infection, the body's primary defense is often wiped out. ANKTIVA represents a paradigm shift—from solely attacking disease to actively re-arming the patient's own immune system. The future of medicine is not just fighting the enemy, but empowering the army within.
3:35

Of all the casualties in the war on cancer, the most critical have been the most ignored: your NK and T cells. As Dr. Patrick Soon-Shiong explains, while oncology has long treated the anemia and neutropenia caused by chemotherapy, it has overlooked the destruction of the very immune cells that fight cancer. For 35 years, there was no treatment for this catastrophic side effect. That era is over. Dr. Soon-Shiong announces ANKTIVA, the first FDA-approved therapy proven to activate NK cells, T cells, and memory T cells. The result? Documented complete responses in bladder cancer patients, free of disease for over nine years. This breakthrough shatters a long-standing medical blind spot. Whether from chemo, radiation, or a severe viral infection, the body's primary defense is often wiped out. ANKTIVA represents a paradigm shift—from solely attacking disease to actively re-arming the patient's own immune system. The future of medicine is not just fighting the enemy, but empowering the army within.

Camus

55,260 görüntüleme • 11 ay önce

A powerful patient story from Dr. Patrick Soon-Shiong's discussion with Sean Spicer: A woman with advanced lung cancer—24 tumors (including thyroid), failed chemo/radiation, given 6-8 weeks to live—joined a trial combining Anktiva (N-803) with Keytruda. After stopping chemo, she felt immediate improvement: eating normally, no weakness, walking, gym, enjoying granddaughter, even running a festival. Scans showed shrinking tumors, thyroid gone; now 4+ years later, thriving with quality of life. Anktiva (FDA-approved 2024 for specific bladder cancer) boosts natural killer cells and T cells—key to immune attack on cancer. Soon-Shiong argues bureaucracy blocks broader access: Right to Try (advocated by Trump/Johnson) gets subverted by FDA delays/IRB hurdles; why require cancer-specific trials when NK-cell boosting helps regardless (like Epogen for anemia)? He's expanding to Canada, Europe, South Africa—where patients see responses in leukemia, etc.—while criticizing US red tape as life-costing. Inspiring remission vs. regulatory frustration: Does this highlight breakthrough potential or need for faster pathways? What's your take on access to immunotherapies like this? Real stories welcome below.
4:51

A powerful patient story from Dr. Patrick Soon-Shiong's discussion with Sean Spicer: A woman with advanced lung cancer—24 tumors (including thyroid), failed chemo/radiation, given 6-8 weeks to live—joined a trial combining Anktiva (N-803) with Keytruda. After stopping chemo, she felt immediate improvement: eating normally, no weakness, walking, gym, enjoying granddaughter, even running a festival. Scans showed shrinking tumors, thyroid gone; now 4+ years later, thriving with quality of life. Anktiva (FDA-approved 2024 for specific bladder cancer) boosts natural killer cells and T cells—key to immune attack on cancer. Soon-Shiong argues bureaucracy blocks broader access: Right to Try (advocated by Trump/Johnson) gets subverted by FDA delays/IRB hurdles; why require cancer-specific trials when NK-cell boosting helps regardless (like Epogen for anemia)? He's expanding to Canada, Europe, South Africa—where patients see responses in leukemia, etc.—while criticizing US red tape as life-costing. Inspiring remission vs. regulatory frustration: Does this highlight breakthrough potential or need for faster pathways? What's your take on access to immunotherapies like this? Real stories welcome below.

Camus

32,930 görüntüleme • 8 ay önce

🚨ImmunityBio’s Anktiva: A New FDA-Approved Immunotherapy for certain bladder cancer. They are also developing treatments that may reduce the need for strong chemo, for blood cancer, lung cancer, brain cancer, and more. Broader approvals may take time. Someone call the President and fast-track this. Dr. Pat Soon-Shiong leads development beyond typical biotech efforts. Most cancer medicines, like chemotherapy, work by poisoning fast-growing cells to kill the cancer. This also hurts healthy cells, causing side effects like hair loss and weakness. Anktiva is different. It is an immunotherapy that wakes up your body’s own immune cells; natural killer cells and T cells to hunt and destroy cancer cells themselves. It acts like a booster shot for your immune system, using a protein called IL-15 to make these cells multiply and remember how to fight cancer long-term. ImmunityBio is different from most companies because of 3 big unique things: 1. They wake up 3 kinds of fighter cells at the same time: • NK cells (natural killers) • CD8 T cells (main attackers) • CD4 T cells (helpers) These three work together like a basketball team. This makes the body remember the cancer for a long time (maybe years). 2. They have a special cell line called NK-92. → It’s like buying frozen pizza instead of making dough from scratch every time. Doctors can just thaw it and give it to any patient. No need to take cells from the sick kid, customize them, and make them super weak with hospital chemo (that’s what normal CAR-T does). 3. Their medicine Anktiva gives a long, steady boost to the immune cells. Older drugs (like IL-2) gave a short, crazy boost that made people very sick. Anktiva is seems safer, so far. Exciting to follow the development. Interview: Chris Cuomo (NewsNation) — “Killing Cancer”
8:29

🚨ImmunityBio’s Anktiva: A New FDA-Approved Immunotherapy for certain bladder cancer. They are also developing treatments that may reduce the need for strong chemo, for blood cancer, lung cancer, brain cancer, and more. Broader approvals may take time. Someone call the President and fast-track this. Dr. Pat Soon-Shiong leads development beyond typical biotech efforts. Most cancer medicines, like chemotherapy, work by poisoning fast-growing cells to kill the cancer. This also hurts healthy cells, causing side effects like hair loss and weakness. Anktiva is different. It is an immunotherapy that wakes up your body’s own immune cells; natural killer cells and T cells to hunt and destroy cancer cells themselves. It acts like a booster shot for your immune system, using a protein called IL-15 to make these cells multiply and remember how to fight cancer long-term. ImmunityBio is different from most companies because of 3 big unique things: 1. They wake up 3 kinds of fighter cells at the same time: • NK cells (natural killers) • CD8 T cells (main attackers) • CD4 T cells (helpers) These three work together like a basketball team. This makes the body remember the cancer for a long time (maybe years). 2. They have a special cell line called NK-92. → It’s like buying frozen pizza instead of making dough from scratch every time. Doctors can just thaw it and give it to any patient. No need to take cells from the sick kid, customize them, and make them super weak with hospital chemo (that’s what normal CAR-T does). 3. Their medicine Anktiva gives a long, steady boost to the immune cells. Older drugs (like IL-2) gave a short, crazy boost that made people very sick. Anktiva is seems safer, so far. Exciting to follow the development. Interview: Chris Cuomo (NewsNation) — “Killing Cancer”

Black Panther Capital

40,249 görüntüleme • 8 ay önce

A Cancer Breakthrough That Changes Everything In a stunning medical advance, Dr. Patrick Soon-Shiong reveals a platform technology achieving near-complete responses in patients with terminal cancers—including brain, pancreatic, and head & neck tumors—after all other treatments failed. This isn't a traditional chemo or radiation. It's a dual approach that empowers the body's own immune system. Here’s the revolutionary breakdown: 1. The "BioShield" Injection: The key is a stabilized form of IL-15 (Interleukin-15), a protein that acts as "food" for your Natural Killer (NK) cells. The NIH tried for a decade to develop IL-15 but failed because it naturally lasts only 2 minutes in the body. Dr. Soon-Shiong's team engineered it to last for 7 days with a simple 5-minute subcutaneous injection, continuously proliferating the patient's NK cells. 2. The Combined Infusion: Patients receive this "BioShield" injection along with an infusion of powerful NK cells, creating a targeted army to attack the cancer. The Proven Results: - Metastatic Pancreatic Cancer: Patients alive 6 years later. - Merkel Cell Carcinoma: Patients surviving 9 years. - Bladder Cancer: Approved by the FDA in April 2024, with patients disease-free for 10 years. - Lung Cancer: In new trials, the therapy has tripled survival for patients who failed everything, including chemo and checkpoint inhibitors. The therapy is also being used preemptively. The NCI has designated it for a trial on patients with Lynch syndrome (1 in 280 Americans), who have an 80% higher risk of cancers, to provide a "Cancer BioShield." The data is based on experience with over 8,000 patients. The challenge now is regulatory. Despite its pan-tumor potential, the current system requires a separate 10-year, 700,000-page approval process for each cancer type. This is a paradigm shift. We don't ask what kind of anemia you have before a blood transfusion. The body needs NK cells and T-cells to fight cancer, regardless of the tumor type.
5:24

A Cancer Breakthrough That Changes Everything In a stunning medical advance, Dr. Patrick Soon-Shiong reveals a platform technology achieving near-complete responses in patients with terminal cancers—including brain, pancreatic, and head & neck tumors—after all other treatments failed. This isn't a traditional chemo or radiation. It's a dual approach that empowers the body's own immune system. Here’s the revolutionary breakdown: 1. The "BioShield" Injection: The key is a stabilized form of IL-15 (Interleukin-15), a protein that acts as "food" for your Natural Killer (NK) cells. The NIH tried for a decade to develop IL-15 but failed because it naturally lasts only 2 minutes in the body. Dr. Soon-Shiong's team engineered it to last for 7 days with a simple 5-minute subcutaneous injection, continuously proliferating the patient's NK cells. 2. The Combined Infusion: Patients receive this "BioShield" injection along with an infusion of powerful NK cells, creating a targeted army to attack the cancer. The Proven Results: - Metastatic Pancreatic Cancer: Patients alive 6 years later. - Merkel Cell Carcinoma: Patients surviving 9 years. - Bladder Cancer: Approved by the FDA in April 2024, with patients disease-free for 10 years. - Lung Cancer: In new trials, the therapy has tripled survival for patients who failed everything, including chemo and checkpoint inhibitors. The therapy is also being used preemptively. The NCI has designated it for a trial on patients with Lynch syndrome (1 in 280 Americans), who have an 80% higher risk of cancers, to provide a "Cancer BioShield." The data is based on experience with over 8,000 patients. The challenge now is regulatory. Despite its pan-tumor potential, the current system requires a separate 10-year, 700,000-page approval process for each cancer type. This is a paradigm shift. We don't ask what kind of anemia you have before a blood transfusion. The body needs NK cells and T-cells to fight cancer, regardless of the tumor type.

Camus

422,251 görüntüleme • 11 ay önce

Dr. Patrick Soon-Shiong reveals the "missing link" in cancer medicine that’s been hiding in plain sight for 450 million years of evolution: Natural Killer (NK) cells — your body’s built-in cancer assassins. Just like red blood cells prevent death from lack of oxygen, NK cells (and T cells) are designed to destroy cancer cells. Yet we’ve ignored them for most of medical history. In 2012, the National Cancer Institute reviewed 240 molecules and declared IL-15 the single most important one for curing cancer — because it supercharges NK cells and T cells. The problem? No one could deliver IL-15 safely and effectively… until Anktiva. 1:51 clip embedded — his passionate delivery makes the breakthrough feel like the missing piece we’ve overlooked for decades. Cancer isn’t just about killing tumors. It’s about waking up the immune system we were born with.
1:51

Dr. Patrick Soon-Shiong reveals the "missing link" in cancer medicine that’s been hiding in plain sight for 450 million years of evolution: Natural Killer (NK) cells — your body’s built-in cancer assassins. Just like red blood cells prevent death from lack of oxygen, NK cells (and T cells) are designed to destroy cancer cells. Yet we’ve ignored them for most of medical history. In 2012, the National Cancer Institute reviewed 240 molecules and declared IL-15 the single most important one for curing cancer — because it supercharges NK cells and T cells. The problem? No one could deliver IL-15 safely and effectively… until Anktiva. 1:51 clip embedded — his passionate delivery makes the breakthrough feel like the missing piece we’ve overlooked for decades. Cancer isn’t just about killing tumors. It’s about waking up the immune system we were born with.

Camus

38,499 görüntüleme • 7 ay önce

Megyn Kelly sat down with Dr. Patrick Soon-Shiong to discuss his revolutionary cancer protocol—a treatment that has already extended lives by years for patients with terminal diagnoses, including the late Senator Harry Reid. The Science Behind the Breakthrough Dr. Soon-Shiong’s approach challenges conventional cancer treatments like chemotherapy and radiation, which destroy the immune system’s natural killer (NK) cells and T-cells—critical for fighting cancer. His BioStripe treatment works by rebuilding the immune system, even in patients who have exhausted all other options. Real Patients, Miraculous Results Merkel cell carcinoma (5th-line treatment): Complete remission—patient lived 6+ years and didn’t die from cancer. Bladder cancer: Patients still alive 10-11 years later. Triple-negative breast cancer: Multiple complete remissions. Metastatic pancreatic cancer: One patient disease-free after 5 years, now 6+ years and counting. FDA Roadblocks & Lost Time Despite undeniable success, Dr. Soon-Shiong faced years of resistance from regulators. In 2015, he proposed testing his method before chemo/radiation—but the FDA insisted on starting with end-stage patients. After 700,000 pages of submissions, approval finally came in late 2024. The Future: Beyond Cancer This treatment isn’t just for cancer—it’s showing promise against sepsis and severe infections. One recent case: A Valley Fever patient on a ventilator, given last rites—fully recovered after treatment. The Urgent Question Why is bureaucracy slowing down a therapy that could save millions? With pancreatic cancer, glioblastoma, and lung cancer patients still dying every day, how many more lives could have been saved if this had been fast-tracked?
3:46

Megyn Kelly sat down with Dr. Patrick Soon-Shiong to discuss his revolutionary cancer protocol—a treatment that has already extended lives by years for patients with terminal diagnoses, including the late Senator Harry Reid. The Science Behind the Breakthrough Dr. Soon-Shiong’s approach challenges conventional cancer treatments like chemotherapy and radiation, which destroy the immune system’s natural killer (NK) cells and T-cells—critical for fighting cancer. His BioStripe treatment works by rebuilding the immune system, even in patients who have exhausted all other options. Real Patients, Miraculous Results Merkel cell carcinoma (5th-line treatment): Complete remission—patient lived 6+ years and didn’t die from cancer. Bladder cancer: Patients still alive 10-11 years later. Triple-negative breast cancer: Multiple complete remissions. Metastatic pancreatic cancer: One patient disease-free after 5 years, now 6+ years and counting. FDA Roadblocks & Lost Time Despite undeniable success, Dr. Soon-Shiong faced years of resistance from regulators. In 2015, he proposed testing his method before chemo/radiation—but the FDA insisted on starting with end-stage patients. After 700,000 pages of submissions, approval finally came in late 2024. The Future: Beyond Cancer This treatment isn’t just for cancer—it’s showing promise against sepsis and severe infections. One recent case: A Valley Fever patient on a ventilator, given last rites—fully recovered after treatment. The Urgent Question Why is bureaucracy slowing down a therapy that could save millions? With pancreatic cancer, glioblastoma, and lung cancer patients still dying every day, how many more lives could have been saved if this had been fast-tracked?

Camus

615,893 görüntüleme • 1 yıl önce

Groundbreaking Cancer research by Dr. Andrea Cercek. Tumors “vanished” in 14 consecutive patients. New data shows another complete 100% response, in all 49 patients. None of her patients needed surgery, chemo or radiation. A monoclonal antibody with “breakthrough status” from the FDA... a new immunotherapy paradigm is evolving, steering the ship away from toxic treatments. Dr. Patrick Soon-Shiong recently said that system destroys the very cells (NK Cells) which protect your body against cancer, mentioning “we’ve been doing it wrong”. New data that emphasises his point: Dr. Andrea Cercek - “The updated data... we treated 49 patients... all 49 patients had a clinical complete response... all 49 of them chose to undergo NON OPERATIVE management... we have not had the issue of taking anyone to surgery”
3:25

Groundbreaking Cancer research by Dr. Andrea Cercek. Tumors “vanished” in 14 consecutive patients. New data shows another complete 100% response, in all 49 patients. None of her patients needed surgery, chemo or radiation. A monoclonal antibody with “breakthrough status” from the FDA... a new immunotherapy paradigm is evolving, steering the ship away from toxic treatments. Dr. Patrick Soon-Shiong recently said that system destroys the very cells (NK Cells) which protect your body against cancer, mentioning “we’ve been doing it wrong”. New data that emphasises his point: Dr. Andrea Cercek - “The updated data... we treated 49 patients... all 49 patients had a clinical complete response... all 49 of them chose to undergo NON OPERATIVE management... we have not had the issue of taking anyone to surgery”

Humanspective

16,695 görüntüleme • 4 ay önce

Dr. Patrick Soon-Shiong Exposes the Cancer Treatment Lie: "Chemo & Radiation Destroy Your Body’s Best Defense—Here’s the Breakthrough That Actually Works" For decades, the world fought cancer with two brutal weapons: chemotherapy and radiation. But what if these treatments weaken the very system designed to save you? Hidden in your body for 460 million years are natural killer cells—your immune system’s elite soldiers against cancer. Yet chemo, radiation, steroids, and even newer drugs like Temodol cripple these cells. One radiation dose can shut them down for a year—leaving patients defenseless when they need protection most. Now, the game has changed. After battling Big Pharma, FDA roadblocks, and systemic resistance, Dr. Soon-Shiong’s team has pioneered a single-injection "Bio-Shield" therapy that activates your body’s natural cancer-fighting army. The results? ✅ Bladder cancer patients disease-free for 10+ years ✅ No toxic chemo or radiation side effects ✅ Potential to treat long COVID, HIV & sepsis The Biden administration blocked this breakthrough—along with COVID treatments—but the dam has broken. The future of medicine isn’t poisoning the body to save it. It’s unleashing the power God put inside us. The full story drops in Cancer Decoded. Follow to learn how we’re ending the era of suffering—and saving millions.
3:48

Dr. Patrick Soon-Shiong Exposes the Cancer Treatment Lie: "Chemo & Radiation Destroy Your Body’s Best Defense—Here’s the Breakthrough That Actually Works" For decades, the world fought cancer with two brutal weapons: chemotherapy and radiation. But what if these treatments weaken the very system designed to save you? Hidden in your body for 460 million years are natural killer cells—your immune system’s elite soldiers against cancer. Yet chemo, radiation, steroids, and even newer drugs like Temodol cripple these cells. One radiation dose can shut them down for a year—leaving patients defenseless when they need protection most. Now, the game has changed. After battling Big Pharma, FDA roadblocks, and systemic resistance, Dr. Soon-Shiong’s team has pioneered a single-injection "Bio-Shield" therapy that activates your body’s natural cancer-fighting army. The results? ✅ Bladder cancer patients disease-free for 10+ years ✅ No toxic chemo or radiation side effects ✅ Potential to treat long COVID, HIV & sepsis The Biden administration blocked this breakthrough—along with COVID treatments—but the dam has broken. The future of medicine isn’t poisoning the body to save it. It’s unleashing the power God put inside us. The full story drops in Cancer Decoded. Follow to learn how we’re ending the era of suffering—and saving millions.

Camus

127,084 görüntüleme • 1 yıl önce

Dr. Patrick Soon-Shiong to Megyn Kelly: For 75 years we've treated cancer like a war—nuking tumors with poisons (chemo) and radiation while simultaneously destroying the immune system's natural killer cells and T-cells. The vicious cycle: Chemo → anemia → give Epogen → more chemo → wipe out neutrophils → give Neupogen → more chemo → destroy more lymphocytes/NK cells. FDA's gold standard? Maximum Tolerated Dose (MTD) — push the poison just below what kills the patient, measure tumor shrinkage (response rate), but ignore overall survival. Soon-Shiong: “The tumor shrinks… but the patient dies. We’re not really interested in overall survival as an endpoint. That is today’s thinking.” Megyn Kelly: “It seems to be a willing choice because we’ve gone so long without making much progress.” Clip from this 2:33 bombshell — the cancer “war” paradigm laid bare. Is MTD + response-rate obsession the reason we’re still losing the fight? Or is this the best we’ve got until something radically better arrives? Your take—seriously, drop it below.
2:33

Dr. Patrick Soon-Shiong to Megyn Kelly: For 75 years we've treated cancer like a war—nuking tumors with poisons (chemo) and radiation while simultaneously destroying the immune system's natural killer cells and T-cells. The vicious cycle: Chemo → anemia → give Epogen → more chemo → wipe out neutrophils → give Neupogen → more chemo → destroy more lymphocytes/NK cells. FDA's gold standard? Maximum Tolerated Dose (MTD) — push the poison just below what kills the patient, measure tumor shrinkage (response rate), but ignore overall survival. Soon-Shiong: “The tumor shrinks… but the patient dies. We’re not really interested in overall survival as an endpoint. That is today’s thinking.” Megyn Kelly: “It seems to be a willing choice because we’ve gone so long without making much progress.” Clip from this 2:33 bombshell — the cancer “war” paradigm laid bare. Is MTD + response-rate obsession the reason we’re still losing the fight? Or is this the best we’ve got until something radically better arrives? Your take—seriously, drop it below.

Camus

29,351 görüntüleme • 6 ay önce

🚨 CANCER SCAM EXPOSED: “Chemo Destroys the Very Cells That Could Save You.” 🚨 Dr. Patrick Soon-Shiong just dropped a bombshell: 🧬 “Chemo. Radiation. Even Temodol — they wipe out your natural killer cells, your body’s best defense against cancer.” 💥 One radiation dose can shut down your immune response for a YEAR. 💥 Steroids, chemo & Big Pharma’s drugs? They’re crippling your only shield. But the truth is out now—and it’s being called "Bio-Shield Therapy." A single injection that reawakens your cancer-killing cells. ✅ Patients with bladder cancer are disease-free 10+ years ✅ No toxic chemo or radiation ✅ Could treat long COVID, HIV & even sepsis ❌ Biden’s FDA blocked this. ❌ Big Pharma fought to bury it. Why? Because you can't patent the immune system God gave you. 🔥 The era of poisoning the body to “save it” is OVER. 🔥 The future of medicine is already here. 📢 FULL STORY in Cancer Decoded. Follow now to learn how we end the suffering—and save millions.
3:53

🚨 CANCER SCAM EXPOSED: “Chemo Destroys the Very Cells That Could Save You.” 🚨 Dr. Patrick Soon-Shiong just dropped a bombshell: 🧬 “Chemo. Radiation. Even Temodol — they wipe out your natural killer cells, your body’s best defense against cancer.” 💥 One radiation dose can shut down your immune response for a YEAR. 💥 Steroids, chemo & Big Pharma’s drugs? They’re crippling your only shield. But the truth is out now—and it’s being called "Bio-Shield Therapy." A single injection that reawakens your cancer-killing cells. ✅ Patients with bladder cancer are disease-free 10+ years ✅ No toxic chemo or radiation ✅ Could treat long COVID, HIV & even sepsis ❌ Biden’s FDA blocked this. ❌ Big Pharma fought to bury it. Why? Because you can't patent the immune system God gave you. 🔥 The era of poisoning the body to “save it” is OVER. 🔥 The future of medicine is already here. 📢 FULL STORY in Cancer Decoded. Follow now to learn how we end the suffering—and save millions.

Jim Ferguson

1,507,915 görüntüleme • 1 yıl önce

Dr. Patrick Soon-Shiong was speaking pretty openly on 2Way’s Cancer Decoded about a long-standing frustration in cancer care. Standard treatments like checkpoint inhibitors, radiation, and chemo can exhaust or destroy your T-cells, the key immune fighters your body needs. But there’s real movement: late 2024, the FDA approved Anktiva (nogapendekin alfa inbakicept-pmln / N-803), an IL-15 receptor agonist. It works by expanding natural killer (NK) cells and memory CD8+ T-cells to help the immune system target hidden cancer cells more effectively, especially in BCG-unresponsive non-muscle invasive bladder cancer. He’s advocating for using low-dose traditional therapies in a smarter, immunomodulating way so the body can actually participate in the fight. This one really got to me. I’ve watched cancer hit people I care about and seen how draining the standard path can be. Hearing someone at his level talk about finally having new tools after 75 years feels like a genuine shift — hopeful, but also a reminder of how slow real change comes in medicine. Cancer treatment has followed the same heavy playbook for generations. If we can better protect and activate the immune system while treating the disease, it could mean less suffering and better real-world outcomes. What do you think — are we at the beginning of a smarter era in cancer treatment, or is it still too early to tell?
1:34

Dr. Patrick Soon-Shiong was speaking pretty openly on 2Way’s Cancer Decoded about a long-standing frustration in cancer care. Standard treatments like checkpoint inhibitors, radiation, and chemo can exhaust or destroy your T-cells, the key immune fighters your body needs. But there’s real movement: late 2024, the FDA approved Anktiva (nogapendekin alfa inbakicept-pmln / N-803), an IL-15 receptor agonist. It works by expanding natural killer (NK) cells and memory CD8+ T-cells to help the immune system target hidden cancer cells more effectively, especially in BCG-unresponsive non-muscle invasive bladder cancer. He’s advocating for using low-dose traditional therapies in a smarter, immunomodulating way so the body can actually participate in the fight. This one really got to me. I’ve watched cancer hit people I care about and seen how draining the standard path can be. Hearing someone at his level talk about finally having new tools after 75 years feels like a genuine shift — hopeful, but also a reminder of how slow real change comes in medicine. Cancer treatment has followed the same heavy playbook for generations. If we can better protect and activate the immune system while treating the disease, it could mean less suffering and better real-world outcomes. What do you think — are we at the beginning of a smarter era in cancer treatment, or is it still too early to tell?

Camus

18,305 görüntüleme • 4 ay önce

Dr. Patrick Soon-Shiong: We've ignored a key CBC metric for 75 years—Absolute Lymphocyte Count (ALC)—your body's count of cancer-fighting NK cells, T cells, memory T cells, B cells, dendritic cells (collectively lymphocytes). Low ALC ( 1,500–1,800 for immune "store." Chemo/radiation/COVID wipe it out—yet until now, nothing to fix it. His breakthrough: ANKTIVA (IL-15 superagonist, "BioShield") unlocks your body's factory to proliferate billions of these cells (FDA-approved for bladder cancer; expanded access/RMAT for lymphopenia reversal in trials). Lymphocytes are the forgotten guardians—ALC is like checking A1C or hemoglobin. Monitor it, boost via sleep/exercise/sunlight, and emerging therapies may restore what toxins deplete. Do you check your ALC on bloodwork? What's your level (or plan to ask next test)? Share experiences.
4:33

Dr. Patrick Soon-Shiong: We've ignored a key CBC metric for 75 years—Absolute Lymphocyte Count (ALC)—your body's count of cancer-fighting NK cells, T cells, memory T cells, B cells, dendritic cells (collectively lymphocytes). Low ALC ( 1,500–1,800 for immune "store." Chemo/radiation/COVID wipe it out—yet until now, nothing to fix it. His breakthrough: ANKTIVA (IL-15 superagonist, "BioShield") unlocks your body's factory to proliferate billions of these cells (FDA-approved for bladder cancer; expanded access/RMAT for lymphopenia reversal in trials). Lymphocytes are the forgotten guardians—ALC is like checking A1C or hemoglobin. Monitor it, boost via sleep/exercise/sunlight, and emerging therapies may restore what toxins deplete. Do you check your ALC on bloodwork? What's your level (or plan to ask next test)? Share experiences.

Camus

68,193 görüntüleme • 8 ay önce

Complete Remission in Glioblastoma After Failed Treatments – A World First? In a remarkable medical milestone, a patient with end-stage glioblastoma—who had failed surgery, radiation, and Temodar—achieved a complete remission in Dr. Patrick Soon-Shiong’s groundbreaking trial. 🔬 Before vs. After MRI: ◀️ LEFT (Before): Tumor crushing the brain’s ventricle, a grim prognosis with no options left. ▶️ RIGHT (After): Tumor virtually gone, ventricle fully reopened—only minimal scarring remains. Dr. Soon-Shiong called this "unprecedented" in glioblastoma, a disease where complete responses at this stage were once thought impossible. 💡 What’s Next? Due to this stunning result, the trial is expanding from 20 to 70 patients. If confirmed, this could rewrite the playbook for treating aggressive brain tumors. "We are witnessing what could be a paradigm shift in oncology," said Dr. Soon-Shiong. "This isn’t just a partial response—it’s a complete remission in a patient who had exhausted every option." Stay tuned for updates as this potentially practice-changing study unfolds. Hope is no longer a theory—it’s in the data.
1:15

Complete Remission in Glioblastoma After Failed Treatments – A World First? In a remarkable medical milestone, a patient with end-stage glioblastoma—who had failed surgery, radiation, and Temodar—achieved a complete remission in Dr. Patrick Soon-Shiong’s groundbreaking trial. 🔬 Before vs. After MRI: ◀️ LEFT (Before): Tumor crushing the brain’s ventricle, a grim prognosis with no options left. ▶️ RIGHT (After): Tumor virtually gone, ventricle fully reopened—only minimal scarring remains. Dr. Soon-Shiong called this "unprecedented" in glioblastoma, a disease where complete responses at this stage were once thought impossible. 💡 What’s Next? Due to this stunning result, the trial is expanding from 20 to 70 patients. If confirmed, this could rewrite the playbook for treating aggressive brain tumors. "We are witnessing what could be a paradigm shift in oncology," said Dr. Soon-Shiong. "This isn’t just a partial response—it’s a complete remission in a patient who had exhausted every option." Stay tuned for updates as this potentially practice-changing study unfolds. Hope is no longer a theory—it’s in the data.

Camus

42,773 görüntüleme • 1 yıl önce

Medical pioneer Dr. Patrick Soon-Shiong unveils a paradigm-shifting approach to cancer treatment that could save millions of lives. In an interview, he revealed we already have the key: protecting the immune system FIRST. The current standard of care—chemotherapy and radiation—often destroys a patient’s lymphocytes (NK & T cells), leading to a condition called lymphopenia. For decades, over 300 studies have shown that lymphopenia predicts early mortality, not just in cancer, but in sepsis and trauma. We treat anemia, but we’ve NEVER had an approved treatment for this critical immune deficiency. Until now. Dr. Soon-Shiong’s “Bio-Shield” is that breakthrough. It’s already approved, and the results are profound: Prostate cancer patients treated with the Bio-Shield before radiation achieved complete remission while their lymphocytes were protected. An ovarian cancer patient received the full, brutal course of chemo after the Bio-Shield. Her cancer disappeared, and she proceeded to surgery with a protected immune system. The vision is simple, yet revolutionary: Mandate that ANY patient undergoing radiation or chemotherapy first receives the Bio-Shield to protect their immune system. The treatment isn’t just attacking the cancer; it’s fortifying the body’s own innate ability to fight and survive. The call to action is clear. We don't need to wait for new regulatory hurdles. We need immediate education for doctors and patients across the nation. We have the power to turn the tide. This is the future of medicine: treating the patient's immune system as the most valuable asset in the fight for their life.
2:53

Medical pioneer Dr. Patrick Soon-Shiong unveils a paradigm-shifting approach to cancer treatment that could save millions of lives. In an interview, he revealed we already have the key: protecting the immune system FIRST. The current standard of care—chemotherapy and radiation—often destroys a patient’s lymphocytes (NK & T cells), leading to a condition called lymphopenia. For decades, over 300 studies have shown that lymphopenia predicts early mortality, not just in cancer, but in sepsis and trauma. We treat anemia, but we’ve NEVER had an approved treatment for this critical immune deficiency. Until now. Dr. Soon-Shiong’s “Bio-Shield” is that breakthrough. It’s already approved, and the results are profound: Prostate cancer patients treated with the Bio-Shield before radiation achieved complete remission while their lymphocytes were protected. An ovarian cancer patient received the full, brutal course of chemo after the Bio-Shield. Her cancer disappeared, and she proceeded to surgery with a protected immune system. The vision is simple, yet revolutionary: Mandate that ANY patient undergoing radiation or chemotherapy first receives the Bio-Shield to protect their immune system. The treatment isn’t just attacking the cancer; it’s fortifying the body’s own innate ability to fight and survive. The call to action is clear. We don't need to wait for new regulatory hurdles. We need immediate education for doctors and patients across the nation. We have the power to turn the tide. This is the future of medicine: treating the patient's immune system as the most valuable asset in the fight for their life.

Camus

38,936 görüntüleme • 1 yıl önce

SHOCKING: Cancer is NOT the disease. It’s the symptom of your immune system already collapsing. Dr. Patrick Soon-Shiong just dropped a truth that rewrites everything we thought we knew about cancer and longevity: The real killer isn’t the tumor. It’s when your Absolute Lymphocyte Count (ALC) — drops below 1,000 cells/μL. That’s lymphopenia. We’ve spent 40+ years nuking the symptom with chemo and radiation… while those same treatments deliberately wipe out the exact cells that could have saved you. We treat the tumor and ignore the host. Your ALC is your immune army. Low ALC = defenseless. Now we can understand why there is an explosion in cancer since the Covid vaccine injection, because it lowers your immune system.
1:56

SHOCKING: Cancer is NOT the disease. It’s the symptom of your immune system already collapsing. Dr. Patrick Soon-Shiong just dropped a truth that rewrites everything we thought we knew about cancer and longevity: The real killer isn’t the tumor. It’s when your Absolute Lymphocyte Count (ALC) — drops below 1,000 cells/μL. That’s lymphopenia. We’ve spent 40+ years nuking the symptom with chemo and radiation… while those same treatments deliberately wipe out the exact cells that could have saved you. We treat the tumor and ignore the host. Your ALC is your immune army. Low ALC = defenseless. Now we can understand why there is an explosion in cancer since the Covid vaccine injection, because it lowers your immune system.

Dr. Dawn Michael

401,746 görüntüleme • 1 ay önce

Dr. Patrick Soon-Shiong presents a fundamental paradigm shift in the war on cancer: we must stop destroying the immune system to save the body, and start supercharging it to achieve a permanent cure. The critical flaw of conventional chemotherapy and radiation is their inadvertent destruction of the very immune cells—the lymphocytes—designed to protect us. This often wins a battle but loses the war, leading to metastasis. The solution lies within us. Dr. Soon-Shiong’s work harnesses "God's design": the power of Natural Killer (NK) cells and T-cells. The breakthrough is two-fold: 1. The Activation Key: For the first time, we can effectively activate these cells using a sustained-release form of IL-15, a natural protein. A single injection can create a tenfold increase in the body's innate cancer-killing army. 2. The Army Expansion: We can now draw a patient's blood, grow billions of targeted NK cells in a lab, and reinfuse them, creating a supercharged, augmented immune response. This is not an incremental improvement. It is a move away from the failed strategy of attacking cancer from the inside-out—blocking internal pathways that cancer easily bypasses—to shattering it from the outside-in. The result is data that speaks to a potential cure: patients with metastatic pancreatic cancer alive and disease-free after five years; bladder cancer patients thriving with their organs intact a decade after treatment; long-term remission in aggressive Merkel cell carcinoma. This approach teaches the immune system "T-cell memory," creating a permanent, living surveillance system that stands guard against recurrence. This is the path to long-term survival with quality of life.
5:44

Dr. Patrick Soon-Shiong presents a fundamental paradigm shift in the war on cancer: we must stop destroying the immune system to save the body, and start supercharging it to achieve a permanent cure. The critical flaw of conventional chemotherapy and radiation is their inadvertent destruction of the very immune cells—the lymphocytes—designed to protect us. This often wins a battle but loses the war, leading to metastasis. The solution lies within us. Dr. Soon-Shiong’s work harnesses "God's design": the power of Natural Killer (NK) cells and T-cells. The breakthrough is two-fold: 1. The Activation Key: For the first time, we can effectively activate these cells using a sustained-release form of IL-15, a natural protein. A single injection can create a tenfold increase in the body's innate cancer-killing army. 2. The Army Expansion: We can now draw a patient's blood, grow billions of targeted NK cells in a lab, and reinfuse them, creating a supercharged, augmented immune response. This is not an incremental improvement. It is a move away from the failed strategy of attacking cancer from the inside-out—blocking internal pathways that cancer easily bypasses—to shattering it from the outside-in. The result is data that speaks to a potential cure: patients with metastatic pancreatic cancer alive and disease-free after five years; bladder cancer patients thriving with their organs intact a decade after treatment; long-term remission in aggressive Merkel cell carcinoma. This approach teaches the immune system "T-cell memory," creating a permanent, living surveillance system that stands guard against recurrence. This is the path to long-term survival with quality of life.

Camus

103,022 görüntüleme • 1 yıl önce

Dr. Patrick Soon-Shiong raises alarming concerns in this 3:06 clip about what he believes are major drivers of rising cancer rates—and a potential preventive tool: 1. Radiation exposure (e.g., military pilots in B-2 bombers) wipes out natural killer cells → allows cancer cells to grow. 2. Persistent COVID/spike protein (from infection or vaccine) found in tumor tissue → may act like HPV or hepatitis as a cancer trigger. 3. Undiagnosed Lynch syndrome (1–2 million Americans unaware) → 80% higher risk of colon/endometrial cancer. He highlights Anktiva (N-803) as a breakthrough: - Chosen by NCI to prevent Lynch syndrome cancers (trials at Mayo, Cleveland Clinic already completed). - Tested to prevent radiation-induced cancer. - Yet still waiting on FDA action for broader prevention use after a year. Frustrating to him: A molecule approved for treatment in Saudi Arabia, backed by major academic centers for prevention, sitting in regulatory limbo. Watch the full clip and decide for yourself. What do you make of the radiation, COVID, and genetic predisposition links he’s drawing? Any personal thoughts or questions on Anktiva/prevention? Drop them below.
3:06

Dr. Patrick Soon-Shiong raises alarming concerns in this 3:06 clip about what he believes are major drivers of rising cancer rates—and a potential preventive tool: 1. Radiation exposure (e.g., military pilots in B-2 bombers) wipes out natural killer cells → allows cancer cells to grow. 2. Persistent COVID/spike protein (from infection or vaccine) found in tumor tissue → may act like HPV or hepatitis as a cancer trigger. 3. Undiagnosed Lynch syndrome (1–2 million Americans unaware) → 80% higher risk of colon/endometrial cancer. He highlights Anktiva (N-803) as a breakthrough: - Chosen by NCI to prevent Lynch syndrome cancers (trials at Mayo, Cleveland Clinic already completed). - Tested to prevent radiation-induced cancer. - Yet still waiting on FDA action for broader prevention use after a year. Frustrating to him: A molecule approved for treatment in Saudi Arabia, backed by major academic centers for prevention, sitting in regulatory limbo. Watch the full clip and decide for yourself. What do you make of the radiation, COVID, and genetic predisposition links he’s drawing? Any personal thoughts or questions on Anktiva/prevention? Drop them below.

Camus

70,270 görüntüleme • 8 ay önce